202 related articles for article (PubMed ID: 17879345)
1. Molecular determinants of sarco/endoplasmic reticulum calcium ATPase inhibition by hydroquinone-based compounds.
Lape M; Elam C; Versluis M; Kempton R; Paula S
Proteins; 2008 Feb; 70(3):639-49. PubMed ID: 17879345
[TBL] [Abstract][Full Text] [Related]
2. Molecular determinants of thapsigargin binding by SERCA Ca2+-ATPase: a computational docking study.
Paula S; Ball WJ
Proteins; 2004 Aug; 56(3):595-606. PubMed ID: 15229891
[TBL] [Abstract][Full Text] [Related]
3. Comparison of current docking tools for the simulation of inhibitor binding by the transmembrane domain of the sarco/endoplasmic reticulum calcium ATPase.
Lape M; Elam C; Paula S
Biophys Chem; 2010 Aug; 150(1-3):88-97. PubMed ID: 20167416
[TBL] [Abstract][Full Text] [Related]
4. Peptide inhibitors use two related mechanisms to alter the apparent calcium affinity of the sarcoplasmic reticulum calcium pump.
Afara MR; Trieber CA; Ceholski DK; Young HS
Biochemistry; 2008 Sep; 47(36):9522-30. PubMed ID: 18702513
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of hydroquinone derivatives as novel inhibitors of the sarco/endoplasmic reticulum calcium ATPase.
Paula S; Abell J; Deye J; Elam C; Lape M; Purnell J; Ratliff R; Sebastian K; Zultowsky J; Kempton RJ
Bioorg Med Chem; 2009 Sep; 17(18):6613-9. PubMed ID: 19699645
[TBL] [Abstract][Full Text] [Related]
6. Structure-based virtual screening for novel inhibitors of the sarco/endoplasmic reticulum calcium ATPase and their experimental evaluation.
Deye J; Elam C; Lape M; Ratliff R; Evans K; Paula S
Bioorg Med Chem; 2009 Feb; 17(3):1353-60. PubMed ID: 19117760
[TBL] [Abstract][Full Text] [Related]
7. Identifying the sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA) as a potential target for hypericin--a theoretical study.
Eriksson ES; Eriksson LA
Phys Chem Chem Phys; 2012 Sep; 14(36):12637-46. PubMed ID: 22892582
[TBL] [Abstract][Full Text] [Related]
8. Water-mediated interactions influence the binding of thapsigargin to sarco/endoplasmic reticulum calcium adenosinetriphosphatase.
Paulsen ES; Villadsen J; Tenori E; Liu H; Bonde DF; Lie MA; Bublitz M; Olesen C; Autzen HE; Dach I; Sehgal P; Nissen P; Møller JV; Schiøtt B; Christensen SB
J Med Chem; 2013 May; 56(9):3609-19. PubMed ID: 23574308
[TBL] [Abstract][Full Text] [Related]
9. Total synthesis of two novel subpicomolar sarco/endoplasmatic reticulum Ca2+-ATPase inhibitors designed by an analysis of the binding site of thapsigargin.
Søhoel H; Liljefors T; Ley SV; Oliver SF; Antonello A; Smith MD; Olsen CE; Isaacs JT; Christensen SB
J Med Chem; 2005 Nov; 48(22):7005-11. PubMed ID: 16250659
[TBL] [Abstract][Full Text] [Related]
10. Effects of novel quercetin derivatives on sarco/endoplasmic reticulum Ca2+-ATPase activity.
Blaskovic D; Drzik F; Viskupicova J; Zizkova P; Veverka M; Horakova L
Neuro Endocrinol Lett; 2012; 33 Suppl 3():190-7. PubMed ID: 23353866
[TBL] [Abstract][Full Text] [Related]
11. Novel phenolic inhibitors of the sarco/endoplasmic reticulum calcium ATPase: identification and characterization by quantitative structure-activity relationship modeling and virtual screening.
Paula S; Hofmann E; Burden J; Stanton DT
J Enzyme Inhib Med Chem; 2015 Feb; 30(1):1-8. PubMed ID: 24517371
[TBL] [Abstract][Full Text] [Related]
12. Design and total synthesis of unnatural analogues of the sub-nanomolar SERCA inhibitor thapsigargin.
Andrews SP; Tait MM; Ball M; Ley SV
Org Biomol Chem; 2007 May; 5(9):1427-36. PubMed ID: 17464412
[TBL] [Abstract][Full Text] [Related]
13. The importance of the hydroxyl moieties for inhibition of the Ca(2+)-ATPase by trilobolide and 2,5-di(tert-butyl)-1,4-benzohydroquinone.
Wictome M; Holub M; East JM; Lee AG
Biochem Biophys Res Commun; 1994 Mar; 199(2):916-21. PubMed ID: 8135840
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase by flavonoids: a quantitative structure-activity relationship study.
Ogunbayo OA; Harris RM; Waring RH; Kirk CJ; Michelangeli F
IUBMB Life; 2008 Dec; 60(12):853-8. PubMed ID: 18785622
[TBL] [Abstract][Full Text] [Related]
15. Sarcoplasmic reticulum calcium ATPase is inhibited by organic vanadium coordination compounds: pyridine-2,6-dicarboxylatodioxovanadium(V), BMOV, and an amavadine analogue.
Aureliano M; Henao F; Tiago T; Duarte RO; Moura JJ; Baruah B; Crans DC
Inorg Chem; 2008 Jul; 47(13):5677-84. PubMed ID: 18510311
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of inhibition of Ca2+-transport activity of sarcoplasmic reticulum Ca2+-ATPase by anisodamine.
Pang Y; Li X; Qin S; Zhang H; Chen J
Indian J Biochem Biophys; 2006 Dec; 43(6):351-9. PubMed ID: 17285799
[TBL] [Abstract][Full Text] [Related]
17. Effects of high-affinity inhibitors on partial reactions, charge movements, and conformational States of the Ca2+ transport ATPase (sarco-endoplasmic reticulum Ca2+ ATPase).
Tadini-Buoninsegni F; Bartolommei G; Moncelli MR; Tal DM; Lewis D; Inesi G
Mol Pharmacol; 2008 Apr; 73(4):1134-40. PubMed ID: 18212248
[TBL] [Abstract][Full Text] [Related]
18. Applying linear interaction energy method for rational design of noncompetitive allosteric inhibitors of the sarco- and endoplasmic reticulum calcium-ATPase.
Singh P; Mhaka AM; Christensen SB; Gray JJ; Denmeade SR; Isaacs JT
J Med Chem; 2005 Apr; 48(8):3005-14. PubMed ID: 15828839
[TBL] [Abstract][Full Text] [Related]
19. The widely utilized brominated flame retardant tetrabromobisphenol A (TBBPA) is a potent inhibitor of the SERCA Ca2+ pump.
Ogunbayo OA; Michelangeli F
Biochem J; 2007 Dec; 408(3):407-15. PubMed ID: 17784851
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of novel sodium/potassium-ATPase inhibitors by virtual screening of a compound database.
Stanton DT; Ankenbauer J; Rothgeb D; Draper M; Paula S
Bioorg Med Chem; 2007 Sep; 15(18):6062-70. PubMed ID: 17618121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
